In 2005, Huang et al. reported for the first time the detection of a specific EGFR mutation (exon 19: delE746—A750), using polymerase chain reaction (PCR) followed by direct DNA sequencing of the pleural cell pellet, in one NSCLC patient who responded to gefitinib treatment [29]. Here, EGFR is linked to non-small cell lung carcinoma.